LATEST ONCOPRESCRIBE UPDATES
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
New ASCO Guideline Recommends Germline Testing in ALL Newly Diagnosed Breast Cancer Patients 65 Years or Younger
Long Term Benefits of RUBRACA® Maintenance in Newly Diagnosed Ovarian Cancer
FDA Approves ALECENSA® as Adjuvant Treatment for ALK-Positive Non Small Cell Lung Cancer